CEO Rob Capps notes third quarter's two main achievements: Klein unit's sale focusing more on Seamap unit, and Seamap's record backlog. Anticipates ongoing supply chain challenges limiting production and delivery delays. No expected dividends on preferred stock for foreseeable future.
MIND CTI's CEO is satisfied with the company's performance, emphasizing timely project completions and healthy existing customer demand. Also, gratitude was shown towards Israel-supporting customers and partners.
MIND テクノロジーに関するコメント
fda approved $T2バイオシステムズ(TTOO.US)$ buy now while you still can!!
@OBIfromMEM
@jimmy the trader
まだコメントはありません